InvestorsHub Logo
Followers 17
Posts 259
Boards Moderated 0
Alias Born 03/19/2018

Re: Lykiri post# 406276

Monday, 06/06/2022 1:30:04 PM

Monday, June 06, 2022 1:30:04 PM

Post# of 694825
To close the loop on Sitoiganap (or Gliovac), it appears the marketing authorization application was withdrawn on May 2, 2022.

Product number: EMEA/H/C/003693

Application Details: https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/sitoiganap

Withdrawal Letter: https://www.ema.europa.eu/en/documents/withdrawal-letter/withdrawal-letter-sitoiganap_en.pdf

International Non-proprietary Name (INN): Autologous glioma tumor cells, inactivated / autologous glioma tumor cell lysates, inactivated / allogeneic glioma tumor cells, inactivated / allogenei
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News